Most chronic liver diseases are notoriously asymptomatic, until cirrhosis with clinical decompensation occurs. The use of early diagnosis strategies […]
The present invention relates to a method for treating a subject suffering from a liver disease comprising a step of administering said subject with a […]
This mouse is deficient for TP53INP1 (both isoforms TP53INP1alpha and TP53INP1beta). TP53INP1 is a key stress factor endowed with a tumor suppressor […]
The monoclonal antibody reacts with human and mouse TP53INP1 (both isoforms TP53INP1alpha and TP53INP1beta). TP53INP1 is a key stress factor endowed […]
The monoclonal antibody reacts with human and mouse TP53INP1 (both isoforms TP53INP1alphaƒnand TP53INP1beta). TP53INP1 is a key stress factor endowed […]
HT29MTX10-6 and HT29MTX10-5 cell populations were isolated from the colon cancer cell line by stepwise adaptation to 10-6 M and 10-5 M Methotrexate […]
The invention relates to a method comprising a step of determining the number, concentration and/or proportion of T lymphocytes with a CD4+ CD8??low […]
Following a prospective clinical study that includes 242 patients, the inventors show that hepatocyte-derived MV levels predicted transplantation-free […]
Cirrhosis is a chronic disease of the liver whose prevalence will dramatically increase during the next decade. Cirrhosis can result from a number of […]